Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202

BACKGROUND: ACTG A5202 randomized treatment-naive individuals to tenofovir-emtricitabine (TDF/FTC) or abacavir-lamivudine (ABC/3TC) combined with efavirenz (EFV) or atazanavir/ritonavir (ATV/r). Individuals in the high screening viral load (VL) stratum (≥100,000 copies/mL) had increased rates of vir...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Grant, Philip M., Tierney, Camlin, Budhathoki, Chakra, Daar, Eric S., Sax, Paul E., Collier, Ann C., Fischl, Margaret A., Zolopa, Andrew R., Balamane, Maya, Katzenstein, David
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4060613/
https://ncbi.nlm.nih.gov/pubmed/24334181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hct1406-284
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados